Piscataway, NJ, September 28, 2022– Camber Pharmaceuticals is pleased to announce the addition of Solifenacin Succinate Tablets to its current portfolio.
Solifenacin Succinate Tablets are used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage).
Solifenacin Succinate Tablets from Camber are available in 5 mg and 10 mg strengths. Both strengths are available in 30 and 90 count bottles.
To find out more about Solifenacin Succinate Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
